Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy

NCT02556801 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HAL Allergy